Orange Book Blog

CPhI Conferences will hold a three-day conference on pharmaceutical intellectual property in Mumbai, India, from January 31, 2012 to February 2, 2012.  The first day of the conference will focus on India; the second day will focus on the United States; and the third day will focus on the rest of the world, including Europe, Japan and emerging markets.  I have the honor of speaking on the Hatch-Waxman Act on Day 2.

The complete agenda is as follows:

Day 1: India

• Patent Scenario in India
• Patentability in the Pharmaceutical Industry
• Section 3(d) of the Indian Patent Act
• Data Exclusivity
• Compulsory Licensing
• Patent Oppotions in India–Current Trends
• Trademarks and Copyrights

Day 2: United States

• The United States Patent System
• The Hatch-Waxman Act
• Paragraph IV Certifications
• The America Invents Act
• Biosimilars in the United States
• Freedom to Operate in the United States
• Doctrine of Equivalents
• Polymorphs

Day 3: Europe, Japan and Emerging Markets

• Patent Systems in Europe, Japan and Emerging Markets
• Supplementary Protection Certificates
• Biosimilars in Europe
• Freedom to Operate in the EU
• Doctrine of Equivalents in the EU
• Japanese Patent System

For more information or to register, please visit the conference website.